Two scientists at the David Geffen School of Medicine at UCLA have been awarded nearly $10 million from the National Institutes of Health’s Brain Research Through Advancing Innovative Neurotechnologies® (BRAIN) Initiative.
Melissa Spencer, professor of neurology and a member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA has received a $999,999, three-year grant from the California Institute for Regenerative Medicine.
“When a virus comes into the human population, it takes a while before it settles into a pattern,” Dr. Yang says. “When this hit humans, everybody was susceptible and it was easy for the virus to spread, but once a bunch of people have been infected and/or vaccinated, then it’s not as easy for the virus to spread and a seasonal pattern will emerge if it’s seasonal.”
An automated process that combines natural language processing and machine learning identified people who inject drugs (PWID) in electronic health records more quickly and accurately than current methods that rely on manual record reviews.
Dr. Daniel Geschwind, the Gordon and Virginia MacDonald Distinguished Professor of Human Genetics, Neurology and Psychiatry at UCLA, was awarded the National Academy of Medicine’s (NAM) 2022 Rhoda and Bernard Sarnat International Prize in Mental Health in recognition of his pioneering research and leadership in autism genetics.
The David Geffen School of Medicine at UCLA has been awarded a $13.6 million grant from the Centers for Disease Control and Prevention to continue to study the effectiveness of COVID-19 vaccines and the long-term impact of infection among U.S. health care workers.
First-year medical students received their white coats on September 9 at Royce Hall, where the David Geffen School of Medicine (DGSOM) at UCLA hosted the annual White Coat Ceremony to welcome 175 students into the medical profession.
Analyzing genetic ancestry data from a large genomic repository – the UCLA ATLAS Precision Health Biobank – researchers have found a highly diverse patient population that’s consistent with the global diversity of Los Angeles – one of the most ethnically diverse cities in the world and an ideal location to pursue personalized, precision medicine for underrepresented populations.
Long before he became chief of plastic and reconstructive surgery at the David Geffen School of Medicine at UCLA, Timothy Miller, MD, was a physician with the Army Special Forces during the Vietnam War, receiving a Bronze Star for his service.
The event offered an introduction to the Center for East-West Medicine and its person-centered approach to health and well-being. Speakers addressed how integrative medicine can reduce chronic pain and support disease prevention in vulnerable populations, such as young people and the elderly.
Antoni Ribas, MD, PhD, has received a renewal of an Outstanding Investigator Award from the National Cancer Institute (NCI). The $4.2 million grant over the next seven years will allow Ribas and his team to continue their innovative research on metastatic melanoma.
UCLA researchers report a step forward in the development of an “off-the-shelf” cell therapy that could reduce the severity of graft-versus-host disease in people receiving donor bone marrow transplants for the treatment of blood cancers such as leukemia and lymphoma.